Time-course and regional distribution of the metabolic effects of bromocriptine in the rat brain.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Brain Research

• Publication date

  1985-08-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-8993(85)91069-8PMID 4041797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides

  2005cited by this paper
• Neurochemical effects of some ergot derivatives: A basis for their antiparkinson actions

  2005cited by this paper
• The endocrine profile of bromocriptine: Its application in endocrine diseases

  2005cited by this paper
• Differential behavioral and biochemical effects of four dopaminergic agonists

  2004cited by this paper
• Haloperidol and Cerebral Metabolism in the Conscious Rat: Relation to Pharmacokinetics

  1984cited by this paper
• Dopamine agonist-induced hyperglycemia in rats: structure-activity relationships and mechanisms of action.

  1983cited by this paper
• The cells of origin of cat trigeminothalamic projections: especially in the caudal medulla.

  1983cited by this paper
• Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Multiple dopamine receptors and behavior.

  1983cited by this paper
• Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour.

  1983cited by this paper
• Actions of substance P, MIF, TRH and related peptides in the substantia nigra, caudate nucleus and nucleus accumbens.

  1983cited by this paper
• Corticotectal and corticothalamic efferent projections of SIV somatosensory cortex in cat.

  1983cited by this paper
• Studies of the principal sensory and spinal trigeminal nuclei of the rat: Projections to the superior colliculus, inferior olive, and cerebellum

  1983cited by this paper
• Nomenclature of central and peripheral dopaminergic sites and receptors.

  1982cited by this paper
• The distribution of alterations in energy metabolism in the rat brain produced by apomorphine.

  1982cited by this paper
• Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.

  1982cited by this paper
• Organization of tectospinal neurons in the cat and rat superior colliculus.

  1982cited by this paper
• Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.

  1981cited by this paper
• The hypotheses of different dopamine receptor mechanisms.

  1981cited by this paper
• The role of 5-hydroxytryptamine in dopamine-dependent stereotyped behaviour.

  1981cited by this paper
• Binding of antiparkinsonian ergot derivatives to the dopamine receptor

  1981cited by this paper
• Ergot alkaloids: interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercles.

  1980cited by this paper
• Evidence for an irreversible interaction of bromocryptine with central dopamine receptors

  1980cited by this paper
• Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.

  1980cited by this paper
• Substance P infusion into substantia nigra of the rat: behavioural analysis and involvement of striatal dopamine.

  1979cited by this paper
• Pharmacology of Bromocriptine in Health and Disease

  1979cited by this paper
• Dopamine receptors in the rat frontal cortex: An autoradiographic study

  1979cited by this paper
• Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine.

  1979cited by this paper
• Bromocriptine in the Treatment of Parkinsonism

  1979cited by this paper
• Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists.

  1979cited by this paper
• Distribution and excretion in the rat and monkey of [82Br] bromocriptine.

  1979cited by this paper
• Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase.

  1979cited by this paper
• Efferent connections of the substantia nigra and ventral tegmental area in the rat.

  1979cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities.

  1978cited by this paper
• Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.

  1978cited by this paper
• Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF 25-397, and 29-712: Effects on the metabolism of the biogenic amines in the brain of the rat

  1978cited by this paper
• THE EFFECT OF BROMOCRIPTINE ON RAT STRIATAL ADENYLATE CYCLASE AND RAT BRAIN MONOAMINE METABOLISM

  1978cited by this paper
• Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro.

  1978cited by this paper
• Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.

  1978cited by this paper
• Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154).

  1978cited by this paper
• RELATION BETWEEN PHYSIOLOGICAL FUNCTION AND ENERGY METABOLISM IN THE CENTRAL NERVOUS SYSTEM

  1977cited by this paper
• DIFFERENTIAL EFFECTS OF THREE DOPAMINE AGONISTS: APOMORPHINE, BROMOCRIPTINE AND LERGOTRILE

  1977cited by this paper
• Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man.

  1977cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977cited by this paper
• STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPA

  1976cited by this paper
• Evidence for dopamine receptors mediating sedation in the mouse brain

  1976cited by this paper
• Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.

  1975cited by this paper
• Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.

  1974cited by this paper
• The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method.

  1974cited by this paper
• Dopaminergic Terminals in the Rat Cortex

  1973cited by this paper
• Enhanced amphetamine responses after frontal cortex lesions in the rat.

  1971cited by this paper
• Simultaneous Statistical Inference

  1967cited by this paper

• Dopamine in the nucleus accumbens shell controls systemic glucose metabolism via the lateral hypothalamus and hepatic vagal innervation in rodents.

  2023cites this paper
• The Acute Pharmacological Manipulation of Dopamine Receptors Modulates Judgment Bias in Japanese Quail

  2022cites this paper
• Dopamine and the motivation of cognitive control.

  2019cites this paper
• Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic–Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement

  2017cites this paper
• Spontaneous Eye Blink Rate (EBR) Is Uncorrelated with Dopamine D2 Receptor Availability and Unmodulated by Dopamine Agonism in Healthy Adults

  2017cites this paper
• [18F]-FDG PET neuroimaging in rats with quinpirole-induced checking behavior as a model for obsessive compulsive disorder.

  2016cites this paper
• Dopaminergic modulation of reward and punishment learning

  2014cites this paper
• The Paradoxical Brain: Index

  2011cites this paper
• Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD response.

  2011cites this paper
• Lack of Dopaminergic Modulation of Cognitive Flexibility

  2007cites this paper
• Dopamine D1 and D2 receptors regulate extracellular lactate and glucose concentrations in the nucleus accumbens.

  2007cites this paper
• Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation

  2006cites this paper
• Dopaminergic enhancement of cognitive function.

  2006cites this paper
• Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin

  2005cites this paper
• Methiothepin reduces glucose utilization in forebrain regions of awake rats

  2004cites this paper
• Comparison of Brain Activity between Dopamine D2 Receptor-Knockout and Wild Mice in Response to Dopamine Agonist and Antagonist Assessed by fMRI

  2004cites this paper
• Cognitive effects of the dopamine receptor agonist pergolide.

  2003cites this paper
• Cortical effects of bromocriptine, a D‐2 dopamine receptor agonist, in human subjects, revealed by fMRI

  2001cites this paper
• In vivo characterization of novel full and partial 2-(4-aminophenyl)-N,N-dipropylethylamine dopamine D(2) receptor agonists.

  2000cites this paper
• Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging.

  1998cites this paper
• Functional correlates of nicotine administration: similarity with drugs of abuse

  1998cites this paper
• Mapping of functional changes associated with administration of substances of abuse in the rat.

  1998cites this paper
• Dopaminergic Modulation of Working Memory for Spatial but Not Object Cues in Normal Humans

  1997cites this paper
• PET Measurement of Dopamine D2 Receptor-Mediated Changes in Striatopallidal Function

  1997cites this paper
• Cerebral metabolic effects of serotonin drugs and neurotoxins.

  1996cites this paper
• Cerebral Metabolic Responses to Clomipramine Are Greatly Reduced Following Pretreatment with the Specific Serotonin Neurotoxin Para-Chloroamphetamine (PCA)

  1995cites this paper
• Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats.

  1995cites this paper
• Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality.

  1994cites this paper
• Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats.

  1993cites this paper
• Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats.

  1993cites this paper
• Metabolic mapping of the pharmacological and toxicological effects of dopaminergic drugs in experimental animals.

  1993cites this paper
• Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal.

  1992cites this paper
• Facilitation of Working Memory in Humans by a D2 Dopamine Receptor Agonist

  1992cites this paper
• Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus.

  1992cites this paper
• Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats.

  1991cites this paper
• Parachloroamphetamine selectively alters regional cerebral metabolic responses to the serotonergic agonist metachlorophenylpiperazine in rats.

  1991cites this paper
• Cerebral metabolic effects of CI‐943 (8‐Ethyl‐7,8‐dihydro‐1,3,5‐trimethyl‐1Himidazo[1,2,‐c]pyrazolo[3,4‐e]‐pyrimidine), a potential antipsychotic drug

  1991cites this paper
• Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats.

  1990cites this paper
• Age-associated functional impairments of specific neurotransmitter systems: detection by pharmacological brain metabolism studies and criteria for design of human investigations.

  1990cites this paper
• High-performance liquid chromatographic assay of bromocriptine in rat plasma and brain.

  1990cites this paper
• Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.

  1990cites this paper
• Preferential Metabolic Activation of Subcortical Brain Areas by Acute Administration of Nicotine to Rats

  1990cites this paper
• Cerebral metabolic effects of sigma ligands in the rat.

  1989cites this paper
• Studies of aging using genetically defined rodents: a bibliography.

  1989cites this paper
• Cerebral metabolic effects of σ ligands in the rat

  1989cites this paper
• Dopamine Receptor Changes During Chronic Drug Administration

  1989cites this paper
• RU 24722, a new eburnamine derivative, induces selective alterations in cerebral glucose utilization in freely moving rat.

  1989cites this paper
• Cerebral Glucose Utilization in Rats is Not Altered by Hindlimb Restraint or by Femoral Artery and Vein Cannulation

  1988cites this paper
• Studies of aging using genetically defined rodents: a bibliography.

  1988cites this paper
• [99mTc]-HM-PAO SPECT in Parkinson's Disease

  1988cites this paper
• Metabolite involvement in the behavioral effects of bromocriptine in cats.

  1987cites this paper
• Stimulatory Effect of the D2 Antagonist Sulpiride on Glucose Utilization in Dopaminergic Regions of Rat Brain

  1987cites this paper
• The pattern of functional coupling of brain regions in the awake rat.

  1986cites this paper
• Reduced metabolic response of the aged rat brain to haloperidol

  1985cites this paper
• Arecoline-induced elevations of regional cerebral metabolism in the conscious rat.

  1985cites this paper